Drug Topics - February 2009 - (Page 50) Product Updates FEATURED THIS MONTH: SORE THROAT OTC Cold Relief with Zinc 4 Kids contains no aspirin, acetaminophen, ibuprofen, naproxen, pseudoephedrine, or dextromethorphan. Cepacol Maximum Numbing Sore Throat + Cough Relief Lozenges combines two medications: Benzocaine and dextromethorphan. Deluxe Honeydrop has 20 grams of honey in each bottle. Continued from pg. 38 and suppresses cough. Its active ingredients are benzocaine, dextromethorphan hydrobromide, and glycerin. A directable nozzle targets sore throat pain, then coats and soothes an irritated throat. A sugar-free formulation is available in cherry flavoring. Hyland’s recently launched its new Cold Relief with Zinc 4 Kids. This product, in the form of an oral strip, uses zinc to shorten the duration of colds in combination with traditional homeopathic medications that treat sore throats. Cold Relief with Zinc 4 Kids can be used by children 2 and older, and it contains no aspirin, acetaminophen, ibuprofen, naproxen, pseudoephedrine, or dextromethorphan. Sucrets Ice is a new product category from Insight Pharmaceuticals with particular appeal for children. The fruit-flavored Ice (available in grape and pomegranate) is packaged in six single-use pouches that freeze in about an hour. The product tagline is “Just freeze it and squeeze it!” Designed for adults and children 3 and older, Sucrets Ice slowly melts in the mouth to relieve sore throats. Active ingredients include menthol, pectin, echinacea, and zinc. Insight says the familiar frozen formulation will be of particular interest to parents whose children choke on lozenges or who balk at syrups and sprays. Another new sore throat treatment introduced this season is Deluxe Honeydrop, an organic flavored water infused with a drop of organic honey and “deluxe” premium juices. Among the reasons honey was chosen as the product’s prime ingredient, according to David Luks, Honeydrop’s founder and CEO, was that “studies suggest it may alleviate sore throats and coughs more effectively than most over-the-counter medicines.” One of those studies was performed Dana K. Cassell, a frequent contributor to Drug Topics, lives in North Stratford, New Hampshire. W W W.D R U GTO P I C S .C O M 50 DRUG TOPICS Februar y 2009 COURTESY OF HYLAND’S, DELUXE HONEYDROP COMBE INC. , in 2007 by a research team at Penn State College of Medicine. The Honeydrop product has 20 grams of honey in each bottle, which is equivalent to 4.2 teaspoons of honey. It is available in apple, orange, chamomile, and blueberry flavors. The new Halls Naturals from Cadbury Adams are available with a “soothing honey center.” A company spokesperson emphasized that the cough drops are also good for sore throats. Tylenol Warming Cough & Sore Throat Nighttime is another new self-care treatment for sore throats. Now in Honey Lemon Warming Liquid, its active ingredients are acetaminophen, dextromethorphan, and doxylamine succinate. An adult product, it should not be used by children under 12. http://WWW.DRUGTOPICS.COM
Table of Contents Feed for the Digital Edition of Drug Topics - February 2009 Drug Topics - February 2009 Contents Health-System Edition Group Attempts to Resurrect Pain Care Act HSE Business Management HSE Clinical Letters Up Front Up Front in Depth Community Practice Niche Pharmacies Serve Special Populations Special Report Oral Oncology Drugs New Drugs Update 2008 Approvals OTC New Products Viewpoint Drug Topics - February 2009 Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover2) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 2) Drug Topics - February 2009 - Contents (Page 3) Drug Topics - February 2009 - Contents (Page 4) Drug Topics - February 2009 - Contents (Page 5) Drug Topics - February 2009 - Contents (Page 6) Drug Topics - February 2009 - Contents (Page 7) Drug Topics - February 2009 - Contents (Page 8) Drug Topics - February 2009 - Group Attempts to Resurrect Pain Care Act (Page H1) Drug Topics - February 2009 - HSE Business Management (Page H2) Drug Topics - February 2009 - HSE Business Management (Page H3) Drug Topics - February 2009 - HSE Business Management (Page H4) Drug Topics - February 2009 - HSE Business Management (Page H5) Drug Topics - February 2009 - HSE Clinical (Page H6) Drug Topics - February 2009 - HSE Clinical (Page H7) Drug Topics - February 2009 - HSE Clinical (Page H8) Drug Topics - February 2009 - HSE Clinical (Page 9) Drug Topics - February 2009 - HSE Clinical (Page 10) Drug Topics - February 2009 - Letters (Page 11) Drug Topics - February 2009 - Up Front (Page 12) Drug Topics - February 2009 - Up Front (Page 13) Drug Topics - February 2009 - Up Front in Depth (Page 14) Drug Topics - February 2009 - Up Front in Depth (Page 15) Drug Topics - February 2009 - Up Front in Depth (Page 16) Drug Topics - February 2009 - Up Front in Depth (Page 17) Drug Topics - February 2009 - Up Front in Depth (Page 18) Drug Topics - February 2009 - Up Front in Depth (Page 19) Drug Topics - February 2009 - Up Front in Depth (Page 20) Drug Topics - February 2009 - Community Practice (Page 21) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 22) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 23) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 24) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 25) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 26) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 27) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 28) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 29) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 30) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 31) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 32) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 33) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 34) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 35) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 36) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 37) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 38) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 39) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 40) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 41) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 42) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 43) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 44) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 45) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 46) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 47) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 48) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 49) Drug Topics - February 2009 - OTC (Page 50) Drug Topics - February 2009 - OTC (Page 51) Drug Topics - February 2009 - OTC (Page 52) Drug Topics - February 2009 - New Products (Page 53) Drug Topics - February 2009 - New Products (Page 54) Drug Topics - February 2009 - New Products (Page 55) Drug Topics - February 2009 - New Products (Page 56) Drug Topics - February 2009 - New Products (Page 57) Drug Topics - February 2009 - New Products (Page 58) Drug Topics - February 2009 - New Products (Page 59) Drug Topics - February 2009 - Viewpoint (Page 60) Drug Topics - February 2009 - Viewpoint (Page Cover3) Drug Topics - February 2009 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.